Sumitomo Chemi.

  • Market Cap: Small Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE258G01013
  • NSEID: SUMICHEM
  • BSEID: 542920
INR
465.25
-0.1 (-0.02%)
BSENSE

Dec 05

BSE+NSE Vol: 1.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.13 lacs (-39.70%) Volume

Shareholding (Sep 2025)

FII

3.65%

Held by 131 FIIs

DII

0.96%

Held by 21 DIIs

Promoter

75.00%

What does Sumitomo Chemi. do?

06-Jun-2025

Sumitomo Chemical India Ltd manufactures household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products. As of March 2025, it reported net sales of ₹679 Cr and a net profit of ₹100 Cr, with a market cap of ₹25,853 Cr.

Overview: <BR>Sumitomo Chemical India Ltd is engaged in the manufacturing of household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products, operating within the Pesticides & Agrochemicals industry and classified as a Large Cap company.<BR><BR>History: <BR>Sumitomo Chemical India Ltd was incorporated on 15 February 2000 and transitioned from Private Limited to Public Limited status on 24 November 2018. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 679 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 100 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 25,853 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 51.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.17% <BR>Debt-Equity: -0.15 <BR>Return on Equity: 17.42% <BR>Price to Book: 8.90 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Who are in the management team of Sumitomo Chemi.?

06-Jun-2025

As of March 2022, the management team of Sumitomo Chemi includes Mukul G Asher (Chairman), Chetan Shah (Managing Director), and several directors and officers responsible for the company's operations and strategy.

As of March 2022, the management team of Sumitomo Chemi includes the following individuals:<BR><BR>1. Mukul G Asher - Chairman & Independent Director<BR>2. Chetan Shah - Managing Director<BR>3. B V Bhargava - Independent Director<BR>4. Ninad D Gupta - Director<BR>5. Preeti Mehta - Independent Director<BR>6. Sushil Marfatia - Executive Director<BR>7. Masanori Uzawa - Director<BR>8. Suresh Ramachandran - Whole-time Director<BR>9. Deepika Trivedi - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

When is the next results date for Sumitomo Chemi.?

06-Jun-2025

No Upcoming Board Meetings

Has Sumitomo Chemi. declared dividend?

06-Jun-2025

Yes, Sumitomo Chemical India Ltd has declared a 9% dividend (₹0.9 per share) with an ex-date of July 19, 2024. While recent performance shows mixed returns, the company has demonstrated positive growth over the longer term, especially with a total return of 92.31% over the past five years.

Yes, Sumitomo Chemical India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 9%<BR>- Amount per share: 0.9<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.17%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -6.03%, with a dividend return of 0%, resulting in a total return of -6.03%.<BR><BR>For the 1-year period, the price return was 8.21%, the dividend return was 0.18%, leading to a total return of 8.39%.<BR><BR>Over the 2-year period, the price return was 25.17%, the dividend return was 1.66%, resulting in a total return of 26.83%.<BR><BR>In the 3-year period, the price return was 7.24%, the dividend return was 1.98%, culminating in a total return of 9.22%.<BR><BR>During the 4-year period, the price return was 45.11%, with a dividend return of 2.30%, giving a total return of 47.41%.<BR><BR>For the 5-year period, the price return was 88.86%, the dividend return was 3.45%, resulting in a total return of 92.31%.<BR><BR>Overall, Sumitomo Chemical India Ltd has declared a dividend, and while the recent performance shows mixed returns, the longer-term trends indicate positive growth, particularly over the 5-year period.

Read More

Who are the peers of the Sumitomo Chemi.?

03-Jun-2025

Sumitomo Chemi.'s peers include P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries. Dhanuka Agritech shows the highest growth and return, while Bharat Rasayan has the lowest return, with Sumitomo Chemi. achieving an 8.51% return.

Peers: The peers of Sumitomo Chemi. are P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci. and Dhanuka Agritech, while Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, and the rest have Average management risk. Growth is Excellent at Dhanuka Agritech, while Excellent capital structure is noted for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, and Bharat Rasayan, with the rest showing Below Average growth and Below Average capital structure.<BR><BR>Return Snapshot: Dhanuka Agritech has the highest 1-year return at 32.65%, while Bharat Rasayan has the lowest at -12.17%, with Sumitomo Chemi.'s 1-year return at 8.51% being higher than Bharat Rasayan's but lower than Dhanuka Agritech's. Additionally, UPL, Bhagiradha Chem., Bharat Rasayan, and NACL Industries have negative six-month returns.

Read More

Is Sumitomo Chemi. overvalued or undervalued?

09-Jun-2025

As of February 14, 2020, Sumitomo Chemical India Ltd. is considered very expensive and overvalued, with a PE ratio of 51.25 and a Price to Book Value of 8.93, despite a strong ROCE of 23.07%, indicating it trades at a premium compared to its peers and has underperformed in longer-term returns.

As of 14 February 2020, the valuation grade for Sumitomo Chemical India Ltd. has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 51.25, a Price to Book Value of 8.93, and an EV to EBITDA of 40.28, all of which suggest that the stock is trading at a premium compared to its earnings and asset values.<BR><BR>In comparison to its peers, Sumitomo Chemical India Ltd. stands out with a PE ratio of 51.25, while its closest competitor has a lower valuation, reinforcing its overvalued status. Additionally, the company's return on capital employed (ROCE) is a strong 23.07%, but this does not offset the high valuation metrics. Notably, while the stock has outperformed the Sensex over the past week and month, it has lagged behind in year-to-date and longer-term returns, further supporting the conclusion that it is overvalued in the current market context.

Read More

Who are the top shareholders of the Sumitomo Chemi.?

17-Jul-2025

The top shareholders of Sumitomo Chemical include Sumitomo Chemical Co. Ltd. with 75.0%, mutual funds with 6.27%, foreign institutional investors at 3.63%, HSBC Small Cap Fund as the largest public shareholder at 1.09%, and individual investors holding 10.14%. This indicates a strong promoter presence in the company.

The top shareholders of Sumitomo Chemical include the following:<BR><BR>1. **Promoter with the highest holding**: Sumitomo Chemical Co. Ltd., which holds 75.0% of the shares.<BR>2. **Mutual Funds**: A total of 30 schemes collectively hold 6.27%.<BR>3. **Foreign Institutional Investors (FIIs)**: 131 FIIs hold 3.63%.<BR>4. **Highest Public Shareholder**: HSBC Small Cap Fund, with a holding of 1.09%.<BR>5. **Individual Investors**: They collectively hold 10.14% of the shares.<BR><BR>This distribution highlights a strong promoter presence in the company, particularly from Sumitomo Chemical Co. Ltd.

Read More

How big is Sumitomo Chemi.?

24-Jul-2025

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, with recent Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,901.14 Cr and Total Assets of 3,963.28 Cr.

Read More

Are Sumitomo Chemi. latest results good or bad?

28-Oct-2025

Sumitomo Chemical India's latest results are unfavorable, with a 7.55% decline in net profit and a 5.92% drop in revenue year-on-year for Q2 FY26, indicating operational challenges in the agrochemical sector. The stock is also underperforming, trading 22.11% below its 52-week high.

The latest results for Sumitomo Chemical India indicate a challenging performance. In Q2 FY26, the company reported a net profit of ₹177.77 crore, which is a decline of 7.55% year-on-year. Revenue also fell by 5.92% year-on-year, totaling ₹929.82 crore. This decline in revenue was accompanied by a significant sequential drop of 12.01% from the previous quarter.<BR><BR>Operating margins showed some improvement sequentially, rising to 23.45% from 20.74% in the previous quarter, but this still represents a year-on-year contraction of 137 basis points. The overall financial performance reflects pressures on both revenue and profitability, raising concerns about demand conditions in the agrochemical sector.<BR><BR>Additionally, the stock has underperformed compared to broader market indices, trading 22.11% below its 52-week high. Given these factors, the results can be characterized as unfavorable, highlighting operational challenges and a need for the company to address its growth trajectory moving forward.

Read More

Should I buy, sell or hold Sumitomo Chemi.?

28-Oct-2025

How has been the historical performance of Sumitomo Chemi.?

28-Oct-2025

Sumitomo Chemi experienced significant fluctuations in financial performance from March 2019 to March 2025, with net sales and operating income dropping to zero by March 2025, while maintaining a strong asset base and achieving profitability in profit before tax and profit after tax. Despite operational losses, total assets grew from 3,368.71 Cr to 3,963.28 Cr during this period.

Answer:<BR>The historical performance of Sumitomo Chemi shows significant fluctuations in key financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Sumitomo Chemi's net sales peaked at 3,510.97 Cr in March 2023 but dropped to 0.00 Cr by March 2025. The total operating income followed a similar trend, decreasing from 3,510.97 Cr in March 2023 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was 2,844.37 Cr in March 2023 and increased to 2,516.47 Cr in March 2025. Operating profit (PBDIT) showed a decline from 711.45 Cr in March 2023 to -2,516.47 Cr in March 2025, indicating a significant operational loss. Despite this, profit before tax improved from 654.18 Cr in March 2023 to 680.24 Cr in March 2025, while profit after tax also saw an increase from 502.21 Cr to 506.44 Cr in the same period. The company's total assets grew from 3,368.71 Cr in March 2023 to 3,963.28 Cr in March 2025, reflecting a strong asset base despite the operational challenges. Cash flow from operating activities decreased from 757.00 Cr in March 2024 to 452.00 Cr in March 2025, and the net cash outflow was recorded at -8.00 Cr in March 2025. Overall, while Sumitomo Chemi faced operational difficulties leading to losses, it maintained a solid asset position and managed to achieve profitability in terms of tax and net profit.

Read More

Is Sumitomo Chemi. technically bullish or bearish?

17-Nov-2025

As of November 14, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 14 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST and Dow Theory are also indicating bearish trends on the weekly, while the monthly signals are mildly bearish. The stock has underperformed significantly compared to the Sensex over various periods, further supporting the bearish outlook.

Read More

Why is Sumitomo Chemi. falling/rising?

04-Dec-2025

As of 04-Dec, Sumitomo Chemical India Ltd's stock price is slightly rising at 462.00, but it has underperformed over the past year with a return of -15.23%, significantly lower than the Sensex's +5.32%. The stock is also trading below its moving averages, indicating a longer-term downward trend.

As of 04-Dec, Sumitomo Chemical India Ltd's stock price is experiencing a slight rise, currently at 462.00, with a change of 0.15 (0.03%) upward. This increase can be attributed to a recent trend where the stock has gained for the last two days, resulting in a total return of 0.45% during this period. Additionally, the stock's performance today is reported to be in line with its sector.<BR><BR>However, it is important to note that despite this recent uptick, the stock has been underperforming in the longer term. Over the past year, it has generated a return of -15.23%, which is significantly lower than the Sensex's return of +5.32% during the same period. The stock is also trading below its moving averages across various time frames, indicating a general downward trend. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 73.35% against the five-day average.<BR><BR>In summary, while there is a minor rise in the stock price recently, the overall long-term performance remains weak, characterized by poor growth metrics and underperformance relative to benchmarks.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 5.60% and Operating profit at 9.35% over the last 5 years

 
2

Flat results in Sep 25

3

With ROE of 17, it has a Very Expensive valuation with a 7.2 Price to Book Value

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 22,858 Cr (Small Cap)

stock-summary
P/E

43.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.26%

stock-summary
Debt Equity

-0.34

stock-summary
Return on Equity

16.97%

stock-summary
Price to Book

7.21

Revenue and Profits:
Net Sales:
930 Cr
(Quarterly Results - Sep 2025)
Net Profit:
178 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.26%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.31%
0%
-18.31%
6 Months
-10.08%
0.23%
-9.85%
1 Year
-16.52%
0.22%
-16.3%
2 Years
13.34%
1.72%
15.06%
3 Years
-5.47%
1.74%
-3.73%
4 Years
24.72%
2.48%
27.2%
5 Years
51.77%
3.45%
55.22%

Latest dividend: 1.2 per share ex-dividend date: Jul-25-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sumitomo Chemical India Ltd has declared 12% dividend, ex-date: 25 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
5.60%
EBIT Growth (5y)
9.35%
EBIT to Interest (avg)
94.67
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.33
Tax Ratio
25.41%
Dividend Payout Ratio
79.69%
Pledged Shares
0
Institutional Holding
12.12%
ROCE (avg)
32.87%
ROE (avg)
18.58%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
40
Price to Book Value
7.24
EV to EBIT
37.08
EV to EBITDA
33.28
EV to Capital Employed
10.39
EV to Sales
6.67
PEG Ratio
3.48
Dividend Yield
0.26%
ROCE (Latest)
28.03%
ROE (Latest)
16.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 32 Schemes (6.56%)

FIIs

Held by 131 FIIs (3.65%)

Promoter with highest holding

Sumitomo Chemical Company Limited (75.0%)

Highest Public shareholder

Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver Fund (1.42%)

Individual Investors Holdings

9.83%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -12.01% vs 55.54% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -0.32% vs 79.09% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "929.82",
          "val2": "1,056.78",
          "chgp": "-12.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "218.03",
          "val2": "219.19",
          "chgp": "-0.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.24",
          "val2": "1.66",
          "chgp": "34.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "177.77",
          "val2": "178.34",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.45%",
          "val2": "20.74%",
          "chgp": "2.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 8.72% vs 12.25% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 11.64% vs 55.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,986.59",
          "val2": "1,827.18",
          "chgp": "8.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "437.21",
          "val2": "406.37",
          "chgp": "7.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "2.41",
          "chgp": "61.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "356.10",
          "val2": "318.96",
          "chgp": "11.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.01%",
          "val2": "22.24%",
          "chgp": "-0.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.80% vs -24.12% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 56.22% vs -39.59% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,469.10",
          "val2": "2,169.74",
          "chgp": "13.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "512.48",
          "val2": "334.39",
          "chgp": "53.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.20",
          "val2": "3.80",
          "chgp": "10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "405.91",
          "val2": "259.83",
          "chgp": "56.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.76%",
          "val2": "15.41%",
          "chgp": "5.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -100.00% vs -19.00% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 36.79% vs -26.42% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "2,843.95",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "632.05",
          "val2": "474.58",
          "chgp": "33.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.86",
          "val2": "5.11",
          "chgp": "14.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "505.50",
          "val2": "369.54",
          "chgp": "36.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.07%",
          "val2": "16.69%",
          "chgp": "3.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
929.82
1,056.78
-12.01%
Operating Profit (PBDIT) excl Other Income
218.03
219.19
-0.53%
Interest
2.24
1.66
34.94%
Exceptional Items
0.00
0.00
Consolidate Net Profit
177.77
178.34
-0.32%
Operating Profit Margin (Excl OI)
23.45%
20.74%
2.71%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is -12.01% vs 55.54% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -0.32% vs 79.09% in Jun 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
1,986.59
1,827.18
8.72%
Operating Profit (PBDIT) excl Other Income
437.21
406.37
7.59%
Interest
3.90
2.41
61.83%
Exceptional Items
0.00
0.00
Consolidate Net Profit
356.10
318.96
11.64%
Operating Profit Margin (Excl OI)
22.01%
22.24%
-0.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 8.72% vs 12.25% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 11.64% vs 55.50% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,469.10
2,169.74
13.80%
Operating Profit (PBDIT) excl Other Income
512.48
334.39
53.26%
Interest
4.20
3.80
10.53%
Exceptional Items
0.00
0.00
Consolidate Net Profit
405.91
259.83
56.22%
Operating Profit Margin (Excl OI)
20.76%
15.41%
5.35%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.80% vs -24.12% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 56.22% vs -39.59% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
0.00
2,843.95
-100.00%
Operating Profit (PBDIT) excl Other Income
632.05
474.58
33.18%
Interest
5.86
5.11
14.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
505.50
369.54
36.79%
Operating Profit Margin (Excl OI)
20.07%
16.69%
3.38%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -100.00% vs -19.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 36.79% vs -26.42% in Mar 2024

stock-summaryCompany CV
About Sumitomo Chemical India Ltd stock-summary
stock-summary
Sumitomo Chemical India Ltd
Small Cap
Pesticides & Agrochemicals
Sumitomo Chemical India Limited (SCIL) was incorporated originally on 15 February 2000 and converted from Private Limited to Public Limited w.e.f. 24th November 2018. SCIL is a subsidiary of Sumitomo Chemical Company Limited, Japan (SCCL). The Company is engaged in manufacturing of household insecticides, agricultural pesticides, public health insecticides and animal nutrition products.
Company Coordinates stock-summary
Icon
No Company Details Available